202 related articles for article (PubMed ID: 25818039)
1. One size may not fit all: the debate of universal tumor testing for Lynch syndrome.
Lu KH; Ring KL
Gynecol Oncol; 2015 Apr; 137(1):2-3. PubMed ID: 25818039
[No Abstract] [Full Text] [Related]
2. Comparison of two Lynch screening strategies in endometrial cancer in a California health system.
Lentz SE; Salyer CV; Dontsi M; Armstrong MA; Hoodfar E; Alvarado MM; Avila M; Nguyen NT; Powell CB
Gynecol Oncol; 2020 Jul; 158(1):158-166. PubMed ID: 32386910
[TBL] [Abstract][Full Text] [Related]
3. Targeted Screening With Combined Age- and Morphology-Based Criteria Enriches Detection of Lynch Syndrome in Endometrial Cancer.
Lin DI; Hecht JL
Int J Surg Pathol; 2016 Jun; 24(4):297-305. PubMed ID: 26842347
[TBL] [Abstract][Full Text] [Related]
4. Impact of an immunohistochemistry-based universal screening protocol for Lynch syndrome in endometrial cancer on genetic counseling and testing.
Frolova AI; Babb SA; Zantow E; Hagemann AR; Powell MA; Thaker PH; Gao F; Mutch DG
Gynecol Oncol; 2015 Apr; 137(1):7-13. PubMed ID: 25617771
[TBL] [Abstract][Full Text] [Related]
5. Performance characteristics of screening strategies for Lynch syndrome in unselected women with newly diagnosed endometrial cancer who have undergone universal germline mutation testing.
Ferguson SE; Aronson M; Pollett A; Eiriksson LR; Oza AM; Gallinger S; Lerner-Ellis J; Alvandi Z; Bernardini MQ; MacKay HJ; Mojtahedi G; Tone AA; Massey C; Clarke BA
Cancer; 2014 Dec; 120(24):3932-9. PubMed ID: 25081409
[TBL] [Abstract][Full Text] [Related]
6. Testing for lynch syndrome in people with endometrial cancer using immunohistochemistry and microsatellite instability-based testing strategies - A systematic review of test accuracy.
Stinton C; Fraser H; Al-Khudairy L; Court R; Jordan M; Grammatopoulos D; Taylor-Phillips S
Gynecol Oncol; 2021 Jan; 160(1):148-160. PubMed ID: 33190932
[TBL] [Abstract][Full Text] [Related]
7. Follow-up recommendations and risk-reduction initiatives for Lynch syndrome.
Guillén-Ponce C; Molina-Garrido MJ; Carrato A
Expert Rev Anticancer Ther; 2012 Oct; 12(10):1359-67. PubMed ID: 23176623
[TBL] [Abstract][Full Text] [Related]
8. Lynch syndrome presenting as endometrial cancer.
Tafe LJ; Riggs ER; Tsongalis GJ
Clin Chem; 2014 Jan; 60(1):111-21. PubMed ID: 24193118
[TBL] [Abstract][Full Text] [Related]
9. Genetic counseling and cascade genetic testing in Lynch syndrome.
Hampel H
Fam Cancer; 2016 Jul; 15(3):423-7. PubMed ID: 26969309
[TBL] [Abstract][Full Text] [Related]
10. [Recognition of congenital endometrial carcinoma: the importance of family history and investigation of microsatellite instability in the tumour].
Hoogerbrugge N; Overbeek LI; de Hullu J; Kets CM; Hebeda KM; Ligtenberg MJ
Ned Tijdschr Geneeskd; 2007 Jun; 151(26):1441-4. PubMed ID: 17633970
[TBL] [Abstract][Full Text] [Related]
11. Performance characteristics of a brief Family History Questionnaire to screen for Lynch syndrome in women with newly diagnosed endometrial cancer.
Eiriksson L; Aronson M; Clarke B; Mojtahedi G; Massey C; Oza AM; Gallinger S; Pollett A; Mackay H; Bernardini MQ; Ferguson SE
Gynecol Oncol; 2015 Feb; 136(2):311-6. PubMed ID: 25529831
[TBL] [Abstract][Full Text] [Related]
12. Clinical characteristics of Lynch-like cases collaterally classified by Lynch syndrome identification strategy using universal screening in endometrial cancer.
Takahashi K; Sato N; Sugawara T; Kato A; Sato T; Shimizu D; Tamura D; Kito M; Makino K; Shirasawa H; Miura H; Sato W; Kumazawa Y; Sato A; Terada Y
Gynecol Oncol; 2017 Nov; 147(2):388-395. PubMed ID: 28847642
[TBL] [Abstract][Full Text] [Related]
13. Selection of endometrial carcinomas for DNA mismatch repair protein immunohistochemistry using patient age and tumor morphology enhances detection of mismatch repair abnormalities.
Garg K; Leitao MM; Kauff ND; Hansen J; Kosarin K; Shia J; Soslow RA
Am J Surg Pathol; 2009 Jun; 33(6):925-33. PubMed ID: 19238076
[TBL] [Abstract][Full Text] [Related]
14. Lynch syndrome.
Backes FJ; Cohn DE
Clin Obstet Gynecol; 2011 Jun; 54(2):199-214. PubMed ID: 21508689
[TBL] [Abstract][Full Text] [Related]
15. Hereditary non-polyposis colorectal cancer or Lynch syndrome: the gynaecological perspective.
Manchanda R; Menon U; Michaelson-Cohen R; Beller U; Jacobs I
Curr Opin Obstet Gynecol; 2009 Feb; 21(1):31-8. PubMed ID: 19125001
[TBL] [Abstract][Full Text] [Related]
16. Targeted Next-Generation Sequencing for Hereditary Cancer Syndromes: A Focus on Lynch Syndrome and Associated Endometrial Cancer.
Tafe LJ
J Mol Diagn; 2015 Sep; 17(5):472-82. PubMed ID: 26162329
[TBL] [Abstract][Full Text] [Related]
17. Lynch syndrome in women less than 50 years of age with endometrial cancer.
Walsh MD; Young J; Spurdle A; Obermair A
Obstet Gynecol; 2008 Oct; 112(4):943. PubMed ID: 18827140
[No Abstract] [Full Text] [Related]
18. The prevalence of Lynch syndrome in women with endometrial cancer: a systematic review protocol.
Ryan NAJ; Blake D; Cabrera-Dandy M; Glaire MA; Evans DG; Crosbie EJ
Syst Rev; 2018 Aug; 7(1):121. PubMed ID: 30115102
[TBL] [Abstract][Full Text] [Related]
19. Identifying Lynch syndrome in patients with endometrial carcinoma: shortcomings of morphologic and clinical schemas.
Clarke BA; Cooper K
Adv Anat Pathol; 2012 Jul; 19(4):231-8. PubMed ID: 22692286
[TBL] [Abstract][Full Text] [Related]
20. Lynch syndrome (hereditary non-polyposis colorectal cancer) and endometrial carcinoma.
Garg K; Soslow RA
J Clin Pathol; 2009 Aug; 62(8):679-84. PubMed ID: 19638537
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
